On November 30, 2015, the sixth subject received their first experimental treatment in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. This subject was enrolled on November 4. Led by Principal Investigator Phil Wolfson, M.D., with co-therapist Julane Andries, LMFT, in Marin, Calif., this study will treat 18 subjects suffering from anxiety related to a life-threatening disease that is either ongoing or in remission with a possibility of recurrence. “I lost my oldest son Noah to leukemia when he was nearly 17. He taught me about the passion to live and to try anything, no matter how difficult, to keep his life going,” recalls Dr. Wolfson in his Winter 2015 MAPS Bulletin article. “Our current study with 18 subjects embraces Noah’s path. His inspiration guides my work with those who struggle with life-threatening illnesses.” We currently expect all experimental sessions in this study will be completed in late 2016.